$3.43
0.278.54%
At close: -
$3.46
0.030.87%
After Hours: Jan 17, 7:58 PM EDT
Comments
Loading...
Perspective Therapeutics (CATX) Forecast
NewsEarningsPerspective Therapeutics (CATX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPerspective Therapeutics (AMEX:CATX) Stock Quotes, Forecast and News Summary
Perspective Therapeutics Stock (AMEX: CATX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Perspective Therapeutics (CATX) stock?
You can purchase shares of Perspective Therapeutics (AMEX:CATX) through any online brokerage.
Who are Perspective Therapeutics (CATX) competitors?
Other companies in Perspective Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Macrogenics (NASDAQ:MGNX), 4D Molecular Therapeutics (NASDAQ:FDMT), Monopar Therapeutics (NASDAQ:MNPR) and Larimar Therapeutics (NASDAQ:LRMR).
What is the forecast, or price target, for Perspective Therapeutics (CATX) stock?
Perspective Therapeutics has a consensus price target of $11.59.
What is the current price for Perspective Therapeutics (CATX)?
The stock price for Perspective Therapeutics (AMEX: CATX) is $3.43 last updated January 17, 2025 at 8:00 PM EST.
Does Perspective Therapeutics (CATX) pay a dividend?
There are no upcoming dividends for Perspective Therapeutics.
When is Perspective Therapeutics (AMEX:CATX) reporting earnings?
Perspective Therapeutics’s Q4 earnings are confirmed for Wednesday, February 12, 2025.
Is Perspective Therapeutics (CATX) going to split?
There is no upcoming split for Perspective Therapeutics.
What sector and industry does Perspective Therapeutics (CATX) operate in?
Perspective Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.